BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1495951)

  • 1. The copper-peroxide-silver method: a highly sensitive procedure for the demonstration of Alzheimer's disease lesions and for signal intensification in immunocytochemistry.
    Velasco ME
    Mod Pathol; 1992 Jul; 5(4):455-63. PubMed ID: 1495951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease.
    DeWitt DA; Silver J; Canning DR; Perry G
    Exp Neurol; 1993 Jun; 121(2):149-52. PubMed ID: 8339766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.
    Ikeda S; Allsop D; Glenner GG
    Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques.
    Ginsberg SD; Crino PB; Lee VM; Eberwine JH; Trojanowski JQ
    Ann Neurol; 1997 Feb; 41(2):200-9. PubMed ID: 9029069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C; Hosokawa M; McGeer PL
    Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are routine methods good enough to stain senile plaques and neurofibrillary tangles in different brain regions of demented patients?
    Mavrogiorgou P; Gertz HJ; Ferszt R; Wolf R; Bär KJ; Juckel G
    Psychiatr Danub; 2011 Dec; 23(4):334-9. PubMed ID: 22075733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 May; 109(5):483-9. PubMed ID: 15759128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
    Czasch S; Paul S; Baumgärtner W
    Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new method for simultaneous demonstration of senile plaques and Alzheimer's neurofibrillary tangles].
    Krutsay M
    Zentralbl Pathol; 1994 Nov; 140(4-5):403-5. PubMed ID: 7826989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silver staining of senile plaques and neurofibrillary tangles in paraffin sections. A simple and effective method.
    Reusche E
    Pathol Res Pract; 1991 Dec; 187(8):1045-9. PubMed ID: 1792186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct types of intraneuronal neurofibrillary tangles highlighted by polarized light after silver impregnation with a modified Bielschowsky method.
    Pappolla MA; Omar R; Theodoropoulos TJ
    Arch Pathol Lab Med; 1991 Feb; 115(2):131-3. PubMed ID: 1992978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer type dementia: diffuse type of senile plaques demonstrated by beta protein immunostaining.
    Yamaguchi H; Hirai S; Shoji M; Harigaya Y; Okamoto Y; Nakazato Y
    Prog Clin Biol Res; 1989; 317():467-74. PubMed ID: 2481323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease.
    Sun A; Nguyen XV; Bing G
    J Neurosci Methods; 2001 Oct; 111(1):17-27. PubMed ID: 11574116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methenamine-silver staining: a simple and sensitive staining method for senile plaques and neurofibrillary tangles.
    Haga C; Ikeda K; Iwabuchi K; Akiyama H; Kondoh H; Kosaka K
    Biotech Histochem; 1994 Sep; 69(5):295-300. PubMed ID: 7819426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
    Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE
    Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.